Zanamivir FDA Link

A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.

Also Known As:

Relenza; 2,3- Didehydro- 2,4- Dideoxy- 4- Guanidino- N- Acetyl- D- Neuraminic Acid; 2,3- Didehydro- 2,4- Dideoxy- 4- Guanidinyl- N- Acetylneuraminic Acid; 4- Guanidino- 2,4- Dideoxy- 2,3- Didehydro- N- Acetylneuraminic Acid; 4- Guanidino- 2- Deoxy- 2,3- Didehydro- N- Acetylneuraminic Acid; 4-Guanidino-Neu5Ac2en; 5- Acetylamino- 2,6- Anhydro- 4- Guanidino- 3,4,5- Trideoxy- D- Galacto- Non- Enoic Acid; GG 167; GG-167; GG167; 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid; 4 Guanidino Neu5Ac2en; Acid, 4- Guanidino- 2- Deoxy- 2,3- Didehydro- N- Acetylneuraminic; 5- acetylamino- 4- guanidino- 6- (1,2,3- trihydroxypropyl)- 5,6- dihydro- 4H- pyran- 2- carboxylic acid

Pharmalogical Action Categories:

Antiviral Agents
Enzyme Inhibitors

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Sugar Acids: 4
      - Neuraminic Acids: 8
        Sialic Acids: 594
        Zanamivir: 732
  - Acyclic Acids
    - Sugar Acids: 4
      - Neuraminic Acids: 8
        Sialic Acids: 594
        Zanamivir: 732
- Amidines: 14
  - Guanidines: 29
    - Zanamivir: 732
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Zanamivir: 732
Carbohydrates: 22023
- Amino Sugars: 110
  - Neuraminic Acids: 8
    - Sialic Acids: 594
      - Zanamivir: 732
- Sugar Acids: 4
  - Neuraminic Acids: 8
    - Sialic Acids: 594
      - Zanamivir: 732

M Dempsey Selected Research

M Dempsey Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure